Brett A Pletcher Gilead Sciences, Inc. (GILD) insider trading activity

Brett A Pletcher is EVP,Corp Affairs & Gen Counsel of GILEAD SCIENCES, INC.. Currently has a direct ownership of 33,426 shares of GILD, which is worth approximately $3.14 Million. The most recent transaction as insider was on Jun 10, 2022, when has been sold 280 shares (Common Stock) at a price of $60.74 per share, resulting in proceeds of $17,007. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.4K

0% 3M change

0% 12M change

Total Value Held $3.14 Million

Brett A Pletcher Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 10 2022	SELL Payment of exercise price or tax liability	$17,007 $60.74 p/Share	280 Reduced 0.83%	33,426 Common Stock
Jun 10 2022	BUY Exercise of conversion of derivative security	-	782 Added 2.27%	33,706 Common Stock
Mar 11 2022	SELL Open market or private sale	$211,644 $58.24 p/Share	3,634 Reduced 10.04%	32,576 Common Stock
Mar 10 2022	SELL Payment of exercise price or tax liability	$120,995 $57.92 p/Share	2,089 Reduced 5.45%	36,210 Common Stock
Mar 10 2022	BUY Exercise of conversion of derivative security	-	5,723 Added 13.0%	38,299 Common Stock
Feb 15 2022	BUY Grant, award, or other acquisition	$18,141 $52.13 p/Share	348 Added 1.05%	32,924 Common Stock
Feb 09 2022	SELL Open market or private sale	$108,038 $63.89 p/Share	1,691 Reduced 4.93%	32,576 Common Stock
Feb 06 2022	SELL Payment of exercise price or tax liability	$66,200 $63.9 p/Share	1,036 Reduced 2.93%	34,267 Common Stock
Feb 06 2022	BUY Exercise of conversion of derivative security	-	2,727 Added 7.17%	35,303 Common Stock
Feb 01 2022	SELL Open market or private sale	$963,741 $68.54 p/Share	14,061 Reduced 30.15%	32,576 Common Stock
Jan 26 2022	SELL Payment of exercise price or tax liability	$382,559 $67.34 p/Share	5,681 Reduced 10.86%	46,637 Common Stock
Jan 26 2022	BUY Grant, award, or other acquisition	-	35,004 Added 40.09%	52,318 Common Stock
Aug 15 2021	BUY Grant, award, or other acquisition	$1,763 $55.08 p/Share	32 Added 0.11%	29,198 Common Stock
Mar 11 2021	SELL Open market or private sale	$94,153 $63.36 p/Share	1,486 Reduced 4.85%	29,166 Common Stock
Mar 10 2021	SELL Payment of exercise price or tax liability	$70,748 $63.91 p/Share	1,107 Reduced 3.49%	30,652 Common Stock
Mar 10 2021	BUY Exercise of conversion of derivative security	-	2,593 Added 7.55%	31,759 Common Stock
Feb 15 2021	BUY Grant, award, or other acquisition	$18,991 $56.86 p/Share	334 Added 1.13%	29,166 Common Stock
Feb 10 2021	SELL Open market or private sale	$133,135 $67.41 p/Share	1,975 Reduced 6.41%	28,832 Common Stock
Feb 06 2021	SELL Payment of exercise price or tax liability	$51,550 $68.46 p/Share	753 Reduced 2.39%	30,807 Common Stock
Feb 06 2021	BUY Exercise of conversion of derivative security	-	2,728 Added 7.96%	31,560 Common Stock
Feb 01 2021	SELL Open market or private sale	$640,635 $65.97 p/Share	9,711 Reduced 25.2%	28,832 Common Stock
Jan 26 2021	SELL Payment of exercise price or tax liability	$249,191 $66.7 p/Share	3,736 Reduced 8.84%	38,543 Common Stock
Jan 26 2021	BUY Grant, award, or other acquisition	-	27,635 Added 39.53%	42,279 Common Stock

Also insider at

CYTK

CYTOKINETICS INC Healthcare

EVP, Chief Legal Officer

BAP

Brett A Pletcher

EVP,Corp Affairs & Gen Counsel

Foster City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Value

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

Operation

Value

Type

News

Receive news related to GILEAD SCIENCES, INC.

Track Activities on GILD

Account